HTL Biotechnology inaugurates a new production line dedicated to sterile Hyaluronic Acid
As part of National Biomanufacturing Day 2025, HTL Biotechnology inaugurates a new production line dedicated to Hyaluronic Acid.
This new edition marks an important milestone in our sustainability journey. It captures the concrete initiatives, strategic choices, and collective energy that have shaped our year. From reducing our environmental footprint to promoting diversity and inclusion, and strengthening dialogue with our stakeholders — every step we’ve taken is part of a long-term vision.
Discover the path HTL Biotechnology is taking to shape a more responsible and innovative future.
Happy reading!
On October 28, 2025, HTL Biotechnology hosted its first-ever webinar, “Shaping the Future of Aesthetic Medicine with Premium Biopolymers,” a key initiative to strengthen our presence in Asia and promote the “Feel the Difference with HTL Inside” positioning among major players in aesthetic medicine.
This October, HTL Biotechnology turned pink to support breast cancer prevention.
HTL Biotechnology is the winner of the Responsible Care West Atlantic Trophy in the ‘Energy – Climate’ category for its project to reduce carbon emissions from distillation systems.